Zusammenfassung
Die interstitiellen Lungenerkrankungen (ILE) des Kindesalters sind eine heterogene Gruppe seltener, chronischer Lungenerkrankungen, die charakterisiert sind durch entzündliche und fibrotische Veränderungen im Bereich der Alveolen und der angrenzenden distalen Atemwege.
Chapter PDF
Similar content being viewed by others
Literatur
Interstitielle Lungenerkrankungen
Clement A;ERS Task. Task force on chronic interstitial lung disease in immunocompetent children. Eur Respir J 2004; 24(4): 686–97
Deutsch GH et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med 2007; 176(11): 1120–8
Clement A, Eber E. Interstitial lung diseases in infants and children. Eur Respir J 2008; 31: 658–66
Kaltenborn E, Kern S, Frixel S, et al. Respiratory syncytial virus potentiates ABCA3 mutation-induced loss of lung epithelial cell differentiation. Hum Mol Genet 2012; 21: 2793–806
Klusmann M, Owens C. HRCT in paediatric diffuse interstitial lung disease - a review for 2009. Pediatr Radiol 2009; 39 Suppl 3: 471–81
EEA, Eosinophile Lungenerkrankungen
Buchwald F, Petersen BL, Damgaard K et al. Frequency, treatment, and functional outcome in children with hypersensitivity pneumonitis. Pediatr Pulmonol 2011; 46: 1098–107
Chen C, Kleinau I, Niggemann B, Weinhold N, Wahn U, Paul K. Treatment of allergic alveolitis with methylprednisolone pulse therapy. Pediatric Allergology and Immunology 2003: 14: 66–70
Cottin V, Cordier JF. Eosinophilic pneumonias. Allergy 2005; 60: 841–847
Fink JN, Ortega HG, Reynolds HY et al. Needs and opportunities for research in hypersensitivity pneumonitis. Am J Respir Crit Care Med 2005; 171(7): 792–798
Janz DR, O’Neal HRJ, Ely EW. Acute eosinophilic pneumonia: a case report and review of the literature. Crit Care Med 2009; 37 (4): 1470–1474
Ratjen F, Costabel U, Griese M, Paul K. Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis. Eur Respir J 2003; 21(1): 144–148
Alveolarproteinose, Surfactant-Anomalien
Griese M, Brasch F, Aldana VR et al. Respiratory disease in Niemann- Pick type C2 is caused by pulmonary alveolar proteinosis. Clin Genet 2010; 77(2): 119–30
Griese M, Nicolai T (Hrsg.) Praktische Pneumologie in der Pdiatrie - Therapie (2012) ISBN 978-3-13-161171–0
Griese M, Ripper J, Sibbersen A et al. Long-term follow-up and treatment of congenital alveolar proteinosis. BMC Pediatr 2011; 17(11): 7–2
Kleinlein B, Griese M, Liebisch G et al. Fatal neonatal respiratory failure in an infant with congenital hypothyroidism due to haploinsufficiency of the NKX2-1 gene: alteration of pulmonary surfactant homeostasis. Arch Dis Child 2010; 96(6): F453–6
Kormann MS, Hasenpusch G, Aneja MK et al. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat Biotechnol 2011; 29(2): 154–7
Nicolai T, Griese M. Praktische Pneumologie in der Pdiatrie - Diagnostik, Rationale Differenzialdiagnostik. Thieme, Stuttgart 2010; ISBN 978-3-13-146081–3
Lungenhmosiderose
Griese M, Nicolai T. Praktische Pneumologie in der Pdiatrie - Therapie. Thieme, Stuttgart 2012. ISBN 978-3-13-161171–0
Lara AR, Frankel SK. Diffuse alveolar hemorrhage. In: Schwarz, King. Interstitial lung disease, 5. Aufl. 2011. Peoples Publishing House, USA, Shelton Connecticut: 805
Nicolai T, Griese M. Praktische Pneumologie in der Pdiatrie - Diagnostik. Thieme, Stuttgart 2010. ISBN 978-3-13-146081–3
Pulmonale Mikrolithiasis Sarkoidose
Griese M, Nicolai T. Praktische Pneumologie in der Pdiatrie - Therapie. Thieme, Stuttgart 2013. ISBN 978-3-13-161171–0
Nicolai T, Griese M. Praktische Pneumologie in der Pdiatrie - Diagnostik. Thieme, Stuttgart 2010. ISBN 978-3-13-146081–3
Rheumatische Erkrankungen mit Lungenbeteiligung
Dell S, Cernelc-Kohan M, Hagood JS. Diffuse and interstitial lung disease and childhood rheumatologic disorders. Curr Opin Rheumatol 2012; 24(5): 530–40
Langerhans-Zell-Histiozytose
Juvet SC, Hwang D, Downey GP. Rare lung diseases III: pulmonary Langerhans cell histiocytosis. Can Respir J 2010; 17(3): e55–62
Histiocyte Society und Gesellschaft für Pädiatrische Onkologie und Hmatologie (i.A. der Deutschen Krebsgesellschaft) Leitlinie L5: Langerhans-Zell-Histiozytose. http://www.krebsgesellschaft.de/ download/ll_l_05.pdf
Ronceray L, Pötschger U, Janka G, Gadner H, Minkov M; German Society for Pediatric Hematology and Oncology, Langerhans Cell Histiocytosis Study Gr. Pulmonary involvement in pediatric-onset multisystem langerhans cell histiocytosis: effect on course and outcome. ## http://www.ncbi.nlm.nih.gov/pubmed/22284564 - #2012; 161(1): 129–133
Hmangiome, Endotheliome und andere Neubildungen
Nicolai T, Griese M. Praktische Pneumologie in der Pdiatrie - Diagnostik. Thieme, Stuttgart 2010. ISBN 978-3-13-146081–3
Haggstrom AN, Garzon MC, Baselga E, et al. Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics. 2010; 126: e418–26
Lipidpneumonien
Griese M, Nicolai T. Praktische Pneumologie in der Pdiatrie - Therapie. Thieme, Stuttgart 2013. ISBN 978-3-13-161171–0
Nicolai T, Griese M. Praktische Pneumologie in der Pdiatrie - Diagnostik. Thieme, Stuttgart 2010. ISBN 978-3-13-146081–3
ABPA
Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002; 110: 685–692
Stevens DA, Moss RB, Kurup VP et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis - State of the Art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37 (suppl 3): S 225–264
Hartl D. Immunologic mechanisms behind the cystic fibrosis-ABPA link. Med Mycol. 2009; 47: S183–S191
Zirbes JM, Milla CE. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol 2008; 43: 607–610
Bronchitis obliterans
Moonnumakal SP, Fan LL. Bronchiolitis obliterans in children. Curr Opin Pediatr 2008; 20(3): 272–8
Zhang L, Irion K, Kozakewich H, et al. Clinical course of postinfectious bronchiolitis obliterans. Pediatr Pulmonol 2000; 29(5): 341–50
Bronchitis fibroplastica
Brogan TV et al. Plastic bronchitis in children: a case series and review of the medical literature. Pediatr Pulmonol 2002; 34(6): 482–7
Medikamentennebenwirkungen
Foucher P, Camus P. Pneumotox online: the drug-induced lung diseases. (Available online at: www.pneumotox.com)
Papillomatosen
Soldatski IL, Onufrieva EK, Steklov AM, Schepin NV. Tracheal, bronchial, and pulmonary papillomatosis in children. Laryngoscope. 2005; 115 (10): 1848–1854
Wierzbicka M, Jackowska J, Bartochowska A, Józefiak A, Szyfter W, Kędzia W. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 2011; 268(9): 1305–1311
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Freihorst, J., Paul, K., Griese, M. (2013). Seltene Lungenerkrankungen. In: von Mutius, E., Gappa, M., Eber, E., Frey, U. (eds) Pädiatrische Pneumologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-34827-3_31
Download citation
DOI: https://doi.org/10.1007/978-3-642-34827-3_31
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-34826-6
Online ISBN: 978-3-642-34827-3
eBook Packages: Medicine (German Language)